| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lixte Biotechnology Holdings, Inc. (LIXT) has 10 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. LIXT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 350.0K | $1.07M | - | |
| CFO | 50.0K | $153.3K | - | |
| Dir | 25.0K | $76.6K | - | |
| Dir | 25.0K | $76.6K | - | |
| Dir | 25.0K | $76.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Van Der Baan Bastiaan Jeroen | President And CEO | Buy | 10,000 | $2.80 | $28,000.00 | +1,000% | |
| Oct 3, 2023 | Bernards Rene | Director | Buy | 10,000 | $2.41 | $24,115.94 | -100% | |
| Dec 30, 2022 | Van Der Baan Bastiaan Jeroen | Director | Buy | 10,000 | $4.90 | $49,000.00 | New | |
| Dec 15, 2022 | Bernards Rene | Director | Buy | 15,000 | $0.51 | $7,650.00 | +11.1% | |
| Dec 12, 2022 | Bernards Rene | Director | Buy | 10,000 | $0.61 | $6,100.00 | +8.0% | |
| Dec 9, 2022 | Forman Eric | Vice President And COO | Buy | 16,112 | $0.61 | $9,836.06 | -100% | |
| Nov 22, 2022 | Forman Eric | Vice President And COO | Buy | 3,941 | $0.56 | $2,206.96 | +2.0% | |
| Nov 21, 2022 | Brown Regina | Director | Buy | 5,000 | $0.58 | $2,876.00 | +100.0% | |
| Nov 18, 2022 | Forman Eric | Vice President And COO | Buy | 21,059 | $0.56 | $11,744.07 | +6.2% | |
| Nov 14, 2022 | Bernards Rene | Director | Buy | 52,500 | $0.53 | $27,825.00 | +72.4% |